Abstract:The 3C-like proteinase (3CLpro) of severe acute respiratory syndrome (SARS) coronavirus has been proposed to be a key target for anti-SARS drug discovery. It has been proposed and verified that the dimer was the active form of 3CLpro and only one protomer is active In our previous work, we measured the dissociation constant (K-d) of the purified SARS 3CLpro using analytical ultracentrifugation at around 14.0 mu mol . L-1 Using this K-d value, most of the SARS 3CLpro in the in vitro activity assay (1-3 mu m . L-1) might be in the monomer form and inactive. To explain this dilemma, we measured the enzyme activity change together with the enzyme concentration. By fitting the concentration dependent activity profile, the apparent dissociation constant was found to be 094 mu mol . L-1. Indicating a clear tendency toward substrate enhanced dimerization. This also explains why SARS 3CLpro was still active in the in vitro activity assay under a relatively low enzyme concentration. To further verify the substrate induced dimerization phenomenon, we selected a previously reported SARS 3CLpro isatin inhibitor, 1-(2-naphthlmethyl) isatin-5-carboxamide (5f), which has similar binding interactions with the substrate and we studied its influence on SARS 3CLpro dimer formation using analytical ultracentrifugation 5f showed a strong ability to Induce SARS 3CLpro dimer formation By measuring the dimer and monomer distribution under different 5f concentrations, the EC50 of dirtier induction was found to be about 1.0 mu mol . L-1 under an enzyme concentration of 3 0 mu mol . L-1. This implies that only one protomer in the SARS 3CLpro choler binds to the inhibitor or the substrate. As the apparent association constant and thus the enzyme activity of SARS 3CLpro increases with the concentration of the substrate, this may be a smart way to allostetrically regulate the hydrolysis of the SARS viral polyproteins and the correct assembly of virons

The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis.

Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.

Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-Like Proteinase

REVISITING THE SARS-COV-2 MAIN PROTEASE: A 2023 IN SILICO ODYSSEY IN SEARCH OF POTENTIAL INHIBITORS

The N-Terminal Octapeptide Acts As A Dimerization Inhibitor of Sars Coronavirus 3C-Like Proteinase

Substrate Binding and Homo-Dimerization of SARS 3CL Proteinase Are Mutual Allosteric Effectors

Rapid Peptide-Based Screening on the Substrate Specificity of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-Like Protease by Matrix-Assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry.

The Substrate Specificity of SARS Coronavirus 3C-Like Proteinase.

Design and bioassay of non-peptidic inhibitors of SARS coronavirus 3C-like proteinase

Virtual Screening of Novel Noncovalent Inhibitors for Sars-Cov 3C-Like Proteinase

Exploring the Efficacy of Noncovalent SARS-CoV-2 Main Protease Inhibitors: A Computational Simulation Analysis Study.

Synthetic Peptides Outside the Spike Protein Heptad Repeat Regions As Potent Inhibitors of Sars-Associated Coronavirus

Electrostatic and Hydrophobic Interactions in SARS Coronavirus Main Proteinase Dimer

Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations

Computational Discovery of SARS-CoV-2 Main Protease Inhibitors Via a Virtual Screening, Molecular Docking, Molecular Dynamics and MM/PBSA Calculations-Driven Approach

Design and evaluation of peptide inhibitors targeting the dimerization of SARS‐CoV‐2 main protease

Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease

Deciphering ACE2-RBD binding affinity through peptide scanning: A molecular dynamics simulation approach

Isatin Dual Functional Inhibitors: Modulating the Aggregation State and Enzyme Activity of SARS-3CL Proteinase

Insight Derived from Molecular Docking and Molecular Dynamics Simulations into the Binding Interactions Between HIV-1 Protease Inhibitors and SARS-CoV-2 3Clpro

3C-Like Proteinase from SARS Coronavirus Catalyzes Substrate Hydrolysis by a General Base Mechanism